Vaccine Nonprofit Execs Banked $9 Million Amid Multi-Million Dollar Losses

The Center Square's investigative reporter Mark Stricherz details his reporting on the Albert B. Sabin Vaccine Institute, a nonprofit founded in 1993 that receives both government and private funding to fight deadly diseases overseas, with a specific focus on the Sudan strain of Ebola and the Marburg virus in Central and East Africa. Stricherz's review of the organization's tax filings found that over the past decade, executive compensation has risen steadily even as the nonprofit's revenue and net income have fluctuated, including significant losses in recent years. The Sabin Institute posted a net loss of nearly $4 million in 2024 and $2 million in 2023 — a combined $6 million loss over two years — while total compensation for executives and other salaried staff rose by $800,000 in 2024 alone, reaching $9 million for that year.